|
Cardiovascular Pharmacology
Citations 461-470 of 1154 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Explaining the Increase in Coronary Heart Disease Mortality in Beijing Between 1984 and 1999
- Julia Critchley, Jing Liu, Dong Zhao, Wang Wei, and Simon Capewell
Circulation published August 30, 2004, doi:10.1161/01.CIR.0000140668.91896.AE
[Abstract]
- Articles
Long-Term Outcome in Elderly Patients With Chronic Angina Managed Invasively Versus by Optimized Medical Therapy. Four-Year Follow-Up of the Randomized Trial of Invasive Versus Medical Therapy in Elderly Patients (TIME)
- Matthias Pfisterer for the TIME Investigators
Circulation published August 30, 2004, doi:10.1161/01.CIR.0000140983.69571.BA
[Abstract]
- Articles
Simvastatin Induces Heme Oxygenase-1. A Novel Mechanism of Vessel Protection
- Tzong-Shyuan Lee, Chih-Chieh Chang, Yi Zhu, and John Y.-J. Shyy
Circulation published August 30, 2004, doi:10.1161/01.CIR.0000140694.67251.9C
[Abstract]
- Coronary Heart Disease
Xuezhikang, an Extract of Cholestin, Protects Endothelial Function Through Antiinflammatory and Lipid-Lowering Mechanisms in Patients With Coronary Heart Disease
- Shui Ping Zhao, Ling Liu, Yan Chun Cheng, Mehdi H. Shishehbor, Ming Hui Liu, Dao Quan Peng, and Yu Ling Li
Circulation 2004;110:915-920; published online before print as doi:10.1161/01.CIR.0000139985.81163.CE
[Abstract]
[Full text]
- Coronary Heart Disease
Impact of Prolonged Cyclooxygenase-2 Inhibition on Inflammatory Markers and Endothelial Function in Patients With Ischemic Heart Disease and Raised C-Reactive Protein: A Randomized Placebo-Controlled Study
- Peter Bogaty, James M. Brophy, Martin Noel, Luce Boyer, Serge Simard, Fernand Bertrand, and Gilles R. Dagenais
Circulation 2004;110:934-939; published online before print as doi:10.1161/01.CIR.0000139338.12464.5F
[Abstract]
[Full text]
- New Drugs and Technologies
Should Angiotensin II Receptor Blockers and Statins Be Combined?
- Georg Nickenig
Circulation 2004;110:1013-1020, doi:10.1161/01.CIR.0000139857.85424.45
[Full text]
- Articles
Early Statin Treatment in Patients With Acute Coronary Syndrome. Demonstration of the Beneficial Effect on Atherosclerotic Lesions by Serial Volumetric Intravascular Ultrasound Analysis During Half a Year After Coronary Event: The ESTABLISH Study
- Shinya Okazaki, Takayuki Yokoyama, Katsumi Miyauchi, Kazunori Shimada, Takeshi Kurata, Hitoshi Sato, and Hiroyuki Daida
Circulation published August 23, 2004, doi:10.1161/01.CIR.0000140261.58966.A4
[Abstract]
- Coronary Heart Disease
Randomized, Double-Blind, Placebo-Controlled Trial of Oral Sirolimus for Restenosis Prevention in Patients With In-Stent Restenosis: The Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) Trial
- Jörg Hausleiter, Adnan Kastrati, Julinda Mehilli, Michael Vogeser, Dietlind Zohlnhöfer, Helmut Schühlen, Christoph Goos, Jürgen Pache, Franz Dotzer, Gisela Pogatsa-Murray, Josef Dirschinger, Uwe Heemann, Albert Schömig for the OSIRIS Investigators
Circulation 2004;110:790-795; published online before print as doi:10.1161/01.CIR.0000138935.17503.35
[Abstract]
[Full text]
- New Drugs and Technologies
Update on Statins: 2003
- Carl J. Vaughan and Antonio M. Gotto, Jr
Circulation 2004;110:886-892, doi:10.1161/01.CIR.0000139312.10076.BA
[Full text]
- Articles
Beneficial Effects of Chronic Pharmacological Manipulation of  -Adrenoreceptor Subtype Signaling in Rodent Dilated Ischemic Cardiomyopathy
- Ismayil Ahmet, Melissa Krawczyk, Phillip Heller, Chanil Moon, Edward G. Lakatta, and Mark I. Talan
Circulation published August 16, 2004, doi:10.1161/01.CIR.0000139844.15045.F9
[Abstract]
|
|
